Skip to content
Review

Biophysical considerations for designing viruses, lipid nanoparticles and virus-like particles for CRISPR-based genome editing.

Jul 2026 · Journal of Controlled Release · pp. 115204 · 0 citations · 200 references
Medicine

TL;DR

This review examines how biophysical properties of viral vectors, lipid nanoparticles, and hybrid virus-like particles influence editor delivery performance and explores how the notion of carrier systems shifts in diseased states like solid tumour cancers, autoimmune psoriasis of the skin, and the autosomal monogenic cystic fibrosis.

Abstract

CRISPR-based genome editing has opened new pathways towards precision medicine, but its success depends on more than just molecular engineering. Cargo and carrier dynamics are profoundly influenced by the underlying biophysical properties of cells and vectors. Consequently, this domain is moving beyond simple "lock and key" approaches, and towards disease-customised fits. In this review, we examine how biophysical properties of viral vectors, lipid nanoparticles, and hybrid virus-like particles influence editor delivery performance. We examine parameters such as size, cargo capacity, charge, shape, stiffness, membrane composition, internalisation strategies, tropism, endosomal escape, protein corona formation, and immune recognition as key drivers of intelligent, modular engineering. Finally, we explore how the notion of carrier systems shifts in diseased states like solid tumour cancers, autoimmune psoriasis of the skin, and the autosomal monogenic cystic fibrosis, where altered biophysical landscapes demand adaptable, context-informed genome editing solutions.

View source

Similar papers

#gene editing Review Open access Aug 2026

Navigating Quality, Safety, and Analytical Testing Frameworks for Viral Vector–Based Gene Editing Therapies

This article aims to provide a working framework for verifying the potency, genomic integrity, and clinical safety of vector-based gene therapies—one intended to be useful both to laboratories developing these products and to those responsible for regulating them.

Yusra A. Radeef, Z. Abdullah, Eman Fadhel Abbas Awadh · 0 citations
Review Open access Jul 2026

Delivery Systems for Therapeutic Genome Editing: Challenges, Innovations, and Future Perspectives

This review provides a comprehensive overview of current and emerging delivery systems for genome editing, highlighting key innovations, unresolved challenges, and interdisciplinary strategies poised to unlock broader therapeutic potential.

Meijia Yang, Yiqiong Song, Ziyang Wang et al. · 0 citations
Review Open access Aug 2026

Therapeutic CRISPR/Cas9 delivery approaches: strengths, limitations, and a roadmap for clinical translation

A major focus of this review is the inclusion of recent hybrid systems (VLPs, SORT-LNPs) and the recognition that chemical modification of guide RNAs is a critical parameter for therapeutic success and that hybrid systems and stimuli-responsive nanoparticles are poised to dominate the next 5 years of clinical development.

M. Rezaee, F. Izadi, Saeed Nobaharian et al. · 0 citations
Review Open access Jul 2026

Exosome Nanotechnology in Molecular Medicine: Advances, Applications and Challenges in Gene Therapy

Despite their promise, significant challenges remain, including low cargo-loading efficiency, batch heterogeneity, limited scalability and the absence of standardized manufacturing and regulatory frameworks, future research must address these barriers to accelerate the clinical translation of exosome-based therapeutics.

Elza Karabagh, Babek Alibayov, Adil Allahverdiyev · 0 citations
Review Open access Jul 2026

Nanoengineering Systems for Gene Therapy: Mechanisms, Modalities, and Future Directions

The continued convergence of nanotechnology and genome engineering may support the development of personalized medicine strategies that adapt genetic engineering tools for patient-specific applications, thereby improving the safety and reliability of gene-editing therapies.

Raheem Mais, Ayush Kumar, Armand Ahmetaj et al. · 0 citations